Market Watch (WATCH)

[Joemoney]

Economic Data Pushes Dow to 6-Month High
By Haitham Haddadin

NEW YORK (Reuters) - Stocks rallied on Friday, with the blue-chip Dow Jones industrial average hitting a six-month high, after upbeat data on manufacturing, construction and consumer spending raised hopes the economy and corporate profits will rebound soon.

A rosy business outlook from Novellus Systems Inc. (NasdaqNM:NVLS - news), a major producer of chip-making equipment, also helped. Novellus shares soared 14 percent and a sector rally ensued.

``It's an extremely powerful and meaningful rally, based on the economic data, which negate the thought the economy is in recession. That's what the market wants to hear,'' said Peter Cardillo, chief strategist at Global Partners. ``Novellus' bright outlook also added a lot of wood to the fire.''

The Dow surged 262.73 points, or 2.6 percent, to 10,368.86 -- its strongest close since Aug. 27, 2001.

The broader Standard & Poor's 500 Index (^SPX - news) rose 25.05 points, or 2.26 percent, to 1,131.78. The technology-laced Nasdaq Composite Index (^IXIC - news) pulled in a gain of 71.26 points, or 4.12 percent, to 1,802.75.

For the week, the Nasdaq rose 4.54 percent, snapping a four-week losing streak. The Dow average rose for the third straight week, gaining 4.02 percent, while the S&P 500 climbed 3.85 percent.

A key report showed factories had boosted production in February for the first time since July 2000 to meet a wave of new orders as demand for manufactured goods soared. That, plus other data for January showing U.S. consumer spending surged and construction spending grew at its fastest pace in a year, offset a drop in a closely watched consumer sentiment gauge.

``For several months now, the economic data has been stronger than the market,'' said Edward Hemmelgarn, chief investment officer of Shaker Investments, which oversees $2.3 billion. ``People are taking the better economic numbers and, for the first time, believing that that may translate into better corporate (earnings) numbers.''

Semiconductor stocks helped lead Nasdaq's rebound after the update by Novellus, whose shares rallied $5.97 to $48.56. ''There are signs of the downturn going away,'' Novellus Chairman and Chief Executive Richard Hill said. ``We see that February has followed January with continued signs of recovery.''

The Philadelphia Stock Exchange's semiconductor index (^SOXX - news) jumped 11 percent, reflecting gains in the shares of others such as Applied Materials (NasdaqNM:AMAT - news), up $4.51 at $47.98.

``Maybe we can see other companies giving better guidance or even hint at increasing capital spending,'' Cardillo said.

Chip giant Intel Corp. (NasdaqNM:INTC - news) climbed $2.43 to $30.98, helping both the Dow and the Nasdaq. It reported China was set to overtake Japan as its largest Asian customer within two years.

Chartered Semiconductor Manufacturing (NasdaqNM:CHRT - news), the world's third-largest independent foundry, raised its guidance and pointed to a sector rebound. It rose $2.87 to $25.35.

Crown Castle International Corp. (NYSE:CCI - news), the No. 2 wireless tower operator, rose 27 percent, or $1.69, to $7.90, after it reported greater-than-expected leasing revenues for the fourth quarter amid a downturn in the industry.

AT&T Wireless Services Inc. (NYSE:AWE - news) fell sharply as the nation's No. 3 wireless company warned that revenue growth -- excluding a recent acquisition -- will slow due to the weak economy and increased competition. It was the most active stock on the Big Board, slumping $1.49 to $8.60.

Biotechnology companies Invitrogen Corp. (NasdaqNM:IVGN - news) and Protein Design Labs Inc. (NasdaqNM:PDLI - news) sank after each said sales growth in 2002 would be slower than expected. Invitrogen fell $11.52 to $34.12. Protein Design fell 93 cents to $14.94.

PerkinElmer Inc. (NYSE:PKI - news) sank 31.52 percent after the maker of scientific instruments lowered its earnings forecasts and said it would cut 500 jobs and reorganize a unit. Shares plunged $7.25 to $15.75.

But Andrx Corp. (NasdaqNM:ADRX - news) surged 25.29 percent after a federal judge threw out a lawsuit claiming its planned copycat forms of British drugmaker GlaxoSmithKline's drugs Wellbutrin and Zyban infringe Glaxo patents. Andrx jumped $8.46 to $41.91.

A rise in mortgage applications and industrial metal prices, along with a fall in corporate bond yields, helped to push a weekly indicator of U.S. economic activity slightly higher last week, the Economic Cycle Research Institute said.

``It's hanging in at relatively modest growth rates, which is telling you that the recovery is not going to be a gangbusters recovery,'' said Anirvan Banerji, ECRI research director. ``But if it stays here, then we don't see a double-dip recession.''

The Dow muscled right through a key technical ``resistance'' level at 10,300. A close above that level, technical analysts now believe, opens the way to tackle resistance at 10,400 to 10,500.

Resistance -- a level where sellers are likely to emerge -- is now set at 10,500 for the Dow, 1,850 for Nasdaq, and 1,132 for S&P, according to Schaeffersresearch.com.

Support -- where buyers are expected to swoop in -- is at 1,750 for Nasdaq, 10,200 for the Dow, and 1,120 for the S&P. The levels are key elements of technical analysis, which studies prices, volume and charts.

http://biz.yahoo.com/rb/020301/business_markets_stocks_dc_16.html

[Joemoney]

Keep an eye on ISIS

(NASDAQ:ISIS)
http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=ISIP&sid=7666&time=

Profile: http://bigcharts.marketwatch.com/quickchart/qsymbinfo.asp?sid=7666&time=8&freq=1&symb=IS....

NOTE: Ticker symbol has recently changed and Yahoo has not updated it, go to Bigcharts.com or Pinksheets.com to get a quote.

Isis Pharmaceuticals' GeneTrove(TM) Division Initiates Target Validation Collaboration With Merck & Co., Inc.
http://biz.yahoo.com/prnews/020221/lath009a_1.html

Revenue in the quarter rose to $21.7 million from $7.9 million a year ago
more: http://biz.yahoo.com/rf/020207/n07146358_1.html

[Joemoney]

Stocks to Sing Accounting Blues

By Elizabeth Lazarowitz

NEW YORK (Reuters) - The stock market, which has been singing the blues most of this year, will carry that tune into this week as Wall Street's persistent accounting anxiety and investors' glum mood help push stocks lower.

Signs that the U.S. economy is making a comeback could offer the stock market a pick-me-up with a slew of economic data set for release and a speech on the economy by the nation's top central banker on tap.

But it won't be enough to lift the gloom now gripping investors with no relief in sight from the nagging worries about dubious bookkeeping and mounting debt in the U.S. telecom sector that have been plaguing stocks for weeks, analysts said.

``The unfortunate thing for the bull (market) case right now is that the economy is probably out of recession, but now this accounting cloud is really holding things back,'' said Nat Paull, portfolio manager at New Amsterdam Partners, which oversees about $1 billion.

Investors will be awaiting confirmation that the U.S. economy grew faster than previously reported at the end of last year, with fourth-quarter U.S. gross domestic product data due early next week.

Earnings news is likely to take a back seat to other issues, although investors will be tuned in for results from retailers like Gap Inc. (NYSE:GPS - news), Home Depot Inc. (NYSE:HD - news), Lowe's Cos. (NYSE:LOW - news), Target Corp. (NYSE:TGT - news) and Federated Department Stores Inc. (NYSE:FD - news)

Bankrupt high-speed communications firm Global Crossing Ltd. , whose accounting practices are under review by federal regulators, also is set to report results this week.


ECONOMIC PICTURE BRIGHTENS

After months of fretting about recession, economists have been scrambling to raise their forecasts for U.S. growth, increasingly convinced by signs like better retail sales and a narrower trade gap. These signals have raised hopes that the recession that began last March will be short and shallow.

The GDP data, along with reports on personal income and spending, consumer confidence, the manufacturing sector, durable goods, existing and new home sales and construction spending could underpin stocks, analysts said.

Federal Reserve Chairman Alan Greenspan will grab the spotlight when he gives his twice-yearly testimony on the economy to Congress, speaking before the House Financial Services Committee on Wednesday and later testifying before the Senate Banking Committee.

``I still think the market is going to be very concerned with not only accounting issues, but the fact that the market's just been rather weak lately,'' said Jeffrey Kleintop, chief investment adviser at PNC Advisors. ``Investors are just going to be content to sit on the sidelines.''


NO TIME FOR FUNKY BOOKKEEPING

The still developing scandal surrounding bankrupt energy trader Enron Corp. has kicked off a string of earnings restatements and investigations into the validity of Corporate America's accounting that have raised questions about whether some stocks are fairly valued.

Investors are more carefully combing through companies' financial statements before they buy and are ready to run for cover at the first hint of impropriety, analysts said.

Those jitters, along with persistent concerns about bad debt at telecom firms like Qwest Communications International Inc. (NYSE:Q - news), have pummeled the market in recent weeks.

Last week, the Nasdaq Composite Index (^IXIC - news) sank 4.4 percent in a holiday-shortened week. The Dow Jones Industrial Average (^DJI - news) ticked up just 0.65 percent and the Standard & Poor's 500 (^SPX - news) fell 1.3 percent.

Year to date, the Nasdaq is down 11.6 percent, the S&P 500 is off 5.1 percent and the Dow is down 0.5 percent.

The technical outlook also offers little encouragement for better days ahead, analysts said. In eight out of the past 11 bear markets, stocks have climbed off their lows, only to give back a big chunk of that gain before heading significantly higher again, Kleintop said.

If history is any guide, the S&P 500 will test the area around 1,069, giving up about half of the gains it made from three-year lows hit on Sept. 21 to the recent highs of early January, he added.

``There's a negative sentiment and anything negative ... in the accounting area could knock the market down,'' said David Dreman, chairman and chief investment officer of Dreman Value Management, which oversees about $7.5 billion. ``Even if the economic news is only slightly less favorable than expected or slightly under estimates, that could have dampening effect.''


DATA TO FLOOD MARKET

The government's report on fourth-quarter GDP, due on Thursday, is expected to show a rise of 0.8 percent, according to a Reuters poll. The initial 0.2 percent reading surprised the market, which was expecting a contraction in growth.

A day ahead of that, investors will examine a report on January durable goods orders, particularly for the data it provides on capital spending. Durable goods are expected to have risen by 1.6 percent in January after a 1.7 percent gain in December.

More crucial numbers will flood in on Friday, when the Institute for Supply Management, formerly known as the National Association of Purchasing Management, releases its closely watched manufacturing sector survey.

Economists predicted the industry trade group's monthly index rose in February to 50.9 -- indicating growth for the first time since July 2000 -- from a January reading of 49.9.

A report on consumer confidence, put out by a private research group, The Conference Board, will also catch investors' attention next week.

The Consumer Confidence Index, set for release on Tuesday, is widely expected to have halted its rise in February, partly because of the sagging stock market. Economists predicted it fell to 96.8 in February, after a reading of 97.3 in January.

http://biz.yahoo.com/rb/020224/business_column_stocks_outlook_dc_1.html

[Joemoney]

Interesting....Shattering A Stock Split Myth
By David Simons

The reputation of reverse stock splits is the opposite of the good-news image of regular splits. Often, though, the perception is overdone and obscures investment opportunity.

Reverse splits, which reduce shares outstanding, most frequently are used to keep a stock's price above the minimum required to maintain Nasdaq listing. They are viewed as desperate acts by companies that are clueless about reversing their fortunes.

The common impression is that the gambit usually fails and the stocks end up in penny stock purgatory on the Nasdaq bulletin board. The record of reverse splits done last year is far better--made all the more surprising by the persistence of the bear market.

Reflecting the market's continued downturn, the number of companies doing regular splits last year fell 58% to 214, while reverse splits doubled to 106, according to Thomson Financial/First Call.

Of the reverse splits (excluding U.S.-listed foreign shares), 84 are still trading that split when their shares were near or below Nasdaq's $1 minimum. (Six were acquired, four went out of business and six split to facilitate such transactions as spinoffs and special dividends.) Contrary to the popular perception, nearly three-quarters have maintained a post-split price above $1.

Of course, merely staying listed isn't investment opportunity. On a pre-split basis, the average price has barely budged from 52 cents. But 39 of the stocks have risen since their reverse splits--up an average 66%, with all but nine of those up at least 20%. (The 45 losers are down 84% on average, but half remain above the listing cutoff.)

No clear pattern separates the winners and losers--not even market timing. The dozen stocks that reverse-split near the market lows in the month following the Sept. 11 tragedy today are equally divided among gainers and decliners.

The most visible reverse splitters have been beleaguered dot-coms. Yet they accounted for just one-fourth of the 2001 tally, and their post-split performance has actually been better than the total--10 of the 23 are up an average of 79%, with the decliners down 63%.

As the examples accompanying the table describe, the opportunity was in ignoring the reverse-split stigma and focusing on each situation individually. Still, playing reverse splits is risky speculation, not investment. Most of the price-performance winners are small companies that haven't established business track records beyond recent reversals of fortune, and now also bear an albatross of per-share losses being amplified due to split-reduced share count.

Clickherefor reverse-split winners and losers.

2001 Reverse-Split Winners And LosersSources: Thomson Financial/First Call, Nasdaq and company reports. *Based upon split- adjusted price the day before the split. ** Also split 1:3 03/06/00. Winners Price 01/23/02 Change Since Split* Split Date
Snowball.com ** $5.25 317% 1:6 09/24
United Online 5.16 165 1:5 09/26
Corrections Corp. of America 16.29 89 1:10 05/18
j2 Global Communications 4.30 91 1:4 02/08
Quotesmith.com 2.50 16 1:3 03/07
Losers
NetRadio 0.02 -99 10:45 06/14
InterWorld 0.25 -94 1:50 05/22
Network Commerce 0.12 -94 1:15 06/18
Finet.com 0.41 -82 1:12 02/20
2001 Reverse-Split Winners Gallery Snowball.com

The operator of sites targeting young adult interests has the distinction of doing two reverse splits in 2001.

Following the first, at 3-to-1 when shares were at 34 cents, Snowball's price sank like a stone. In September, with shares at 21 cents (down from the split adjusted $1.02), a 6-to-1 reverse split was administered. The price then drifted downward until mid-November, when hoopla about launch of Microsoft's Xbox game console began. Suddenly, investors noticed that Snowball.com operates the largest independent Xbox gaming site, launched a year earlier to update devotees about developments. Snowball.com shares rolled uphill from $1 to $6 in two months. That's not to say Snowball.com is a slam-dunk. Its third-quarter operating loss was $2.9 million on $2.1 million in revenue.United Online

Investors greeted September's merger of Internet service providers Juno and Netzero skeptically. The sub-$1 price of each was remedied by a merger structure that had the effect of a 1-for-5 reverse split.

Recently, there's been optimism about the attractiveness of the company's $9.95 per month unlimited access in the slow economy, and that significant operating economies from the merger will be realized. Though the third quarter's combined operating loss was 56% better than the second quarter, it was $18 million, and United Online hasn't projected profit earlier than December 2002.Corrections Corporation Of America

The prison operator broke out to a 21-month high after a 1-for-10 reverse split in May. The rise came on perception that the company, which has a history of difficulties that include high-profile escapes, has gotten its big houses in order. Third-quarter loss was $5.7 million on $248 million in revenue.J2 Global Communications

Shares of the enhanced-messaging provider soared 91% since reverse-splitting last February. Created by the November 2000 merger of struggling Efax.com and Jfax.com, the company turned the corner in the third quarter and reported a small profit, excluding merger amortization.Quotesmith.com

Despite gaining 16% since its March split, shares of online insurance broker Quotesmith.com are 26% below the $3.37 per share of cash held by the company as of Dec. 31. Cost cutting in 2001 slashed losses to $521,000 by the fourth quarter, enabling the now $18 million cash hoard to last for nine years. Nonetheless, the company still forecasts a losing 2002--under $1 million on revenue of $11 million.

Investors remain skeptical that self-motivated online buying of insurance can ever amount to more than a speck in a market dominated by personal contact selling--particularly of life insurance, which has been Quotesmith.com's focus. Founded in 1984 to provide insurance pricing data to agents, the company has sold just 105,000 policies since beginning online direct selling in 1996. The impact of recent expansion to automobile and homeowners' coverage--and the December acquisition of insurance research site insure.com--has yet to be seen.

That doesn't sound like a real winner. Still, stocks selling at large discounts to cash rarely stay that way for long if the burn rate remains low.

Agree or disagree? Clickhereto discuss the issues raised in this column.

http://biz.yahoo.com/fo/020125/0125simons_1.html

[Joemoney]

SEC CHARGES A GEORGIA INVESTMENT ADVISER AND ITS CONTROLLING SHAREHOLDER WITH
FRAUD

The Commission announced today that it has filed a complaint in the
United States District Court for the Northern District of Georgia
against John Raymond Linney Clain and his investment adviser firm, Saint
James Asset Management, Inc., both of Alpharetta, Georgia. The
complaint alleges that between 1998 and 2000, Clain and Saint James
misappropriated approximately $920,000 from sixteen clients. The
complaint also names Clain Family Corporation, a Georgia company, as a
relief defendant.

The complaint alleges that Clain and Saint James obtained over $960,000
from sixteen clients between January 1998 and October 2000 by
misrepresenting that the clients' money would be used to purchase
various securities. Without the clients' knowledge or permission, Clain
used the money primarily to fund the operations for an Augusta, Georgia
company in which Clain had an interest, Alternate Energy Resources, Inc.
The complaint also alleges that Clain used misappropriated funds to
purchase two cars and a diamond ring, and to pay the mortgage on his
house. Clain Family Corporation, which is controlled by Clain, now owns
one of the cars. It also alleges that the defendants' misconduct
included providing clients with materially false and misleading periodic
account statements that represented falsely that they had bought
specific securities for the clients, when in fact they had.

The SEC's complaint charges Clain and Saint James with violations of
Section 17(a) of the Securities Act of 1933 and Section 10(b) of the
Securities Exchange Act of 1934, and Rule 10b-5 thereunder. The
complaint also charges Clain and Saint James with violations of Sections
206(1) and 206(2) of the Investment Advisers Act of 1940. The SEC seeks
permanent injunctions against Clain and Saint James as well as an order
compelling disgorgement of ill-gotten gains, along with prejudgment
interest and civil penalties. The complaint seeks return of ill-gotten
gains from Clain Family Corporation, the relief defendant. [SEC v.
Saint James Asset Management, Inc. and John Raymond Linney Clain,
Defendants and Clain Family Corporation, Relief Defendant, Civil Action
File No. 1:02-CV-426, N.D. Ga.] (LR-17363)

http://www.sec.gov/news/digest/02-15.txt

[Caradoc]

Company has purposely remained debt free since its beginning. Had $35 million line of credit with Gleneagle (UGH!!) but didn't use a penny of it and ended up cancalling it. Dilution (selling new shares to keep going, apparently) has averaged $2 million shares per year. Iinventor Alvin Snaper registers to sell shares every year. Since he's in mid-seventies and as far as I know gets nothing form his previous patents, my guess is that this is what he lives on.

With low overhead business model of collecting licensing fees, it shouldn't take much cashflow to end the dilution.

On the plus side, largest single shareholder is CEO Lee Balak who recently added another 100,000 shares to his position and waives his salary. Shareholder Wolf M (Meyerfeld?) bought in at the $200,000 level more than a year ago and went to work for no salary doing marketing. Word is that he will be confirmed as a corporate director at next stockholders meeting which would make sense since he's so involved. Wolf posts on RB as "Lolabito." I razzed him a bit about transposed letters because he was trying for "little wolf" in Spanish which would have been "Lobolito." Since he was born in Germany, I guess his Spanish isn't worth bragging about.

Fairly dispassionate ("faint praise") assessment followed by current status from "Nitetrade" who has been in and out of PWTC 3 or 4 times over the last couple of years:
http://ragingbull.lycos.com/mboard/boards.cgi?board=W.T.BEAR&read=7470
http://ragingbull.lycos.com/mboard/boards.cgi?board=W.T.BEAR&read=7699

Nitetrade and I have exchanged emails with me freely admitting thatso far he has made more on PWTC than I have. For example, when it hit 1.03/1.06 but next morning failed to go higher and only showed 1.01/1.03 we both knewthat as a "trade" it was time to bail. He sold his whole position and took nice profit. I sold only half because I'm determined not to be out of it when big news finally happens.

Just my approach....

Caradoc

[Joemoney]

U.S. Markets Closed for President's Day.

[Joemoney]

Does PWTC have any dilution or any other dangers?

The company can make the best product, but dilution is pollution.

Joemoney

[Caradoc]

The rule that BB stocks are for trading, not holding, is an excellent one to follow. 99.99% of them are trash: either scams from the start or at best somebody's dream hoping to come true. You'd probably be better off "investing" in your cousin's new restaurant. Despite this well-deserved nasty reputation (or maybe because of it?) the rare exceptions to the rule (the few that have any chance at all of becoming "real companies") offer the only opportunities I'm aware of for achieving gains measured in thousands of percentage points. Of course, even most of them don't make it because they have to resort to convertible debentures for financing (death spiral!!) or else print shares to stay alive hoping to make it before share value gets diluted to zero.

DNAP is great for trading. Bought at/near the lows, it's a triple whenever genetic approach to health is a hot subject. Given their relationship with ORCH, it could make long holders wealthy if ORCH's approach is successful. And if that happens, it should give a better percentage return than ORCH.

Just my (ongoing and boringly repeated) opinion, but PWTC has the highest perceivable odds of providing huge returns if held long.

Caradoc

[Joemoney]

Small Cap Gold Index

From a fellow poster:

http://finance.yahoo.com/q?s=AAUK+ABX+ADRRF.OB+AEM+APLL.OB+ASL+ASWRF.OB+AU+AZC+BENGB.OB+BGO+BVN+BWLR...

[Joemoney]

Bush Decides Saddam Must Go

President Bush will oust Iraq's Saddam Hussein, and ordered agencies to devise plans to remove him, the Philadelphia Inquirer reported. Unnamed U.S. officials said Bush decided Iraq's nuclear, chemical and biological weapons programs are too threatening to U.S. security. A senior U.S. official told the AP Bush's top advisers were developing ouster strategies, including military.

Source: IBD's Top 10

[Joemoney]

Bristol Seeks Merck Data on Cancer Drug

By Ransdell Pierson

NEW YORK (Reuters) - Bristol-Myers Squibb Co. said it has asked German drug maker Merck KGaA to share its clinical data on experimental cancer drug Erbitux, but declined to say whether it aims to use the European data to bolster Bristol's own uncertain chances of winning U.S. approval for the medicine.

Erbitux is being developed in the United States by tiny New York biotech firm ImClone Systems Inc. (NasdaqNM:IMCL - news) and its partner Bristol-Myers (NYSE:BMY - news), whose relationship has soured since U.S. regulators in December refused to accept ImClone's marketing application for the promising medicine.

Bristol-Myers recently demanded it be given primary responsibility to negotiate the marketing application with the FDA, following ImClone's failure. ImClone rejected the demand.

``We have reached out to Merck and have told them we are interested in getting access to their data on the trials they are doing. It's very useful data to have,' Bristol-Myers spokesman Wilson Grabill told Reuters.

ImClone said Bristol-Myers had not informed the company about its request for the Merck data, nor how Bristol-Myers intends to use it. Bristol-Myers declined to elaborate on their action.

``I wouldn't want to speculate how we would use the (Merck) data,' said Grabill, whose firm is entitled to 40 percent of U.S. profits from Erbitux if it is approved by the FDA. ImClone would keep the remaining 60 percent under their $2 billion co-marketing deal announced last September.

An ImClone spokesman dismissed speculation by one industry analyst that Merck would likely demand royalties from ImClone and Bristol-Myers if they were to use Merck's clinical data for their U.S. marketing application for Erbitux.

ImClone said a provision in its contract requires both ImClone and Merck to provide their respective clinical data to each other for regulatory submission without charge.

``ImClone has all this already, and as ImClone's partner, so has Bristol-Myers,' he said. ``There's no reason for them to get it separately.'

Richard Evans, a Sanford Bernstein drug analyst, said earlier that Merck would no doubt want to be paid handsomely for sharing its data with Bristol-Myers and ImClone, possibly to the tune of hundreds of millions of dollars.

``Merck would definitely want royalties on U.S. Erbitux sales. They'd want to be paid either a sizable fixed fee or a smaller fee plus a percentage of Erbitux revenues,' Evans said.

Merck (quote from Yahoo! UK & Ireland: MRCG.F), which is not related to U.S. drug giant Merck & Co. (NYSE:MRK - news), agreed in 1998 to pay ImClone $60 million for the exclusive rights to sell Erbitux in all global markets, except North America. Profits are to be split in Japan.

ImClone and Merck then designed and conducted their own separate trials of the drug for colon and head-and-neck cancer.

But while ImClone's colon cancer trial was scorned by the FDA, Merck said its own studies have gone so well it expects to win European approval of Erbitux next year.

A source familiar with the U.S. clinical trials said Bristol-Myers apparently hopes it and ImClone can submit Merck's European data to the FDA to get Erbitux approved in the United States if the FDA continues to reject ImClone's own U.S. data.

``The Merck data is Bristol-Myers' backup plan. Their main plan is to see if the FDA will go ahead and accept ImClone's data. But if that fails, they could present the Merck data to the FDA and ask if it meets the FDA's standards for approval,' the source said.

Officials from the FDA and Merck could not immediately be reached for comment.

The FDA usually requires two well-controlled clinical trials before it will approve new medicines, but is typically willing to accept only one such trial for cancer drugs.

http://biz.yahoo.com/rb/020213/business_health_bristolmyers_erbitux_dc_1.html

[Joemoney]

HP Profit Beats Raised Forecast

By Peter Henderson

SAN FRANCISCO (Reuters) - Hewlett-Packard Co. (NYSE:HWP - news) on Wednesday reported first-quarter profits above Wall Street expectations it had raised last week, as consumers snapped up personal computers and printers.

The Palo Alto, California-based company said the results proved management's case it can successfully integrate takeover target Compaq Computer Corp. (NYSE:CPQ - news), but it tempered expectations for the current quarter, saying consumer spending could slow and earnings would fall slightly.

HP posted a net profit of $484 million, or 25 cents per diluted share, for the first quarter ended Jan. 31, up from $141 million, or 7 cents per share, in the year-earlier quarter.

Excluding one-time items and accounting adjustments, HP posted a profit of $564 million, or 29 cents per diluted share, compared with $812 million, or 41 cents per share, in the year-ago quarter.

Sales fell to $11.4 billion from $12.4 billion in the year-earlier quarter.

Analysts polled by research firm Thomson Financial/First Call had forecast operating earnings of 18 cents to 27 cents per share on sales of $11.1 billion. On Feb. 4, HP had said it would substantially beat the existing consensus of 16 cents per share.

Shares in Hewlett-Packard rose to $21.31 in after-hours trade on the Island system, bringing their gain on the day to 2.5 percent. The shares had closed at $20.98 on Nasdaq.

Kevin McCloskey, a portfolio manager at Federated Investors in Pittsburgh who is wary of the merger, said the results topped expectations but did not convince him of the merits of the $22.5 billion deal.

``HP has some good businesses, Compaq has some decent businesses and they think putting one and one together gets two or maybe even three. But I'd say we're not that positive that would happen,'' he said.

Hewlett-Packard said the strong personal computer sales to businesses and consumers returned the total PC business to profit, and digital imaging and outsourcing showed strength.

Profitability rose in imaging and printing, personal computers and IT services, driving the earnings per share surprise.

COMPANY CREDITS COST-CUTTING

Chief Financial Officer Bob Wayman said HP's two-and-a-half year campaign of cost cutting was finally paying off.

``We have been working and working on getting expenses sized to the changed environment and then you see a little bit of an uptick in revenue, and voila, you see a big improvement in the bottom-line,'' he said on a conference call with investors.

Hewlett-Packard has traditionally seen revenue rise in its second quarter from its first, but Wayman said that with corporate spending still slow and economic prospects uncertain, revenues and earnings per share were both likely to decline.

Earnings per share would be consistent with analyst consensus forecasts of around 25 cents per share, he said in an interview.

``The outlook is either disappointing or conservative, depending on how you look at it. But I think most people were expecting revenues to be up sequentially in Q2,'' said Sanford Bernstein analyst Toni Sacconaghi.

Andrew Scott, of Needham & Co., was more positive, saying holiday sales boosted the first quarter. ``It stands to reason they will have more cautious guidance because you're not going to have the digital Christmas phenomenon.''

The results marked the second quarter in a row that HP beat analyst expectations, after a year of disappointments, and Chairman and Chief Executive Carly Fiorina took the opportunity to buttress her arguments for the merger.

``Our execution these past two quarters demonstrates that we're ready to take this decisive step,'' she said in a statement.

``We know our business better than anyone else,'' she added in a conference call. But, she said, ``a lot more is needed. And with Compaq, we have a detailed plan.''

HP says the merger with Compaq will create a computer and services powerhouse, while opponents including founding family heir and dissident director Walter Hewlett say the deal will bloat the company's personal computer business and sap resources better focused on high-end products.

Hewlett said the results simply proved that HP did not need Compaq -- or its low profit PC business. ``We believe HP needs to focus on its strengths,'' he said in a statement.

Hewlett-Packard stock is down about 10 percent from the close on Aug. 31, the last day of trade before it announced plans to merge with Compaq, while rival International Business Machines Corp. has gained about 8 percent since then.

http://biz.yahoo.com/rb/020213/business_tech_hewlettpackard_earns_dc_4.html

[stocko4949]

NICK - has
good consistent growth, about 5 mil shares, makes money, PE of 5 or 6, not a trading stock, but a good investment stock. They are just off of a conference in atlanta in which over 200 investors received "investor pkg's", I would expect some movement within the next 90 days. I do have a position in this company. IMO 6-12 mo. outlook 7.00 to 10.00 (everyone searching the rubble for companies with earnings and value, sooner or later they will find this one). Stocko


http://biz.yahoo.com/e/020213/nick.html

http://www.nicfn.com/

from aug. 6, 2001
http://www.nicfn.com/EpochRep.PDF

standard and poors, aug. 2001
http://www.nicfn.com/S&PStkRp.pdf

[stocko4949]

2 Good Trading Tips I use for more $$$ puddinlegs1132
2/12/02 10:46 pm
$$$ 2 Short Term Trading Tactics:

Post-opening buying:

Let's say a stock rises 5 percent or more during the opening and there's no
news about it. Typically, the stock will fall off after 30 minutes of
trading. Why? Market makers may be trying to open the stock at an
artificially high price to sell off excess inventory they've acquired the day
before. However, if the stock doesn't fall after 30 minutes of trading, it's
liable to continue rising for the rest of the day. Tactic: Buy at 1/16 above
the day's high after the opening. Set a stop at 1/16 below the day's low.

Post-opening selling:

The opposite of the above strategy. When a stock opens lower on no news, it
could be that sell orders from nervous investors have piled up since the
close of trading the day' before. Sometimes market makers open the stock
artificially low, to draw in more panic sellers. This allows them to
accumulate shares, because market makers as a rule buy on price declines and
sell on price increases. After 30 minutes, the stock usually recovers in
price and normal trading begins. The market makers profit by selling the
inventory they've accumulated at the lower price. However, if the stock
continues to drift lower after 30 minutes, chances are it'll decline more
during the course of the day. Tactic: Sell short at 1/16 below the low of the
day; set a stop at 1/16 above the day's high.

[stocko4949]

Caradoc - Q - RE; DNAP

I know BB stocks are for trading,...not meant to hold, but after trading dnap some, and reading up on it, I decided to just hold some long term. What is your take on company,...and its potential?

Stocko

[Caradoc]

Agree completely and am not in either QBID or TXMC. Wouldn't consider QBID as a longterm hold. Just cynical assessment that there's probability of several-fold increase (but not back to 3 cents) from current level as those involved once again begin to suspect that their dream may come true. I just don't have the heart to be in it planning to sell for a triple or whatever into their last or next to last faint rally. For an even more cynical play, you can always check to see whether pinkie Medinah Mining is back to its usual lows. That one -- sadly -- is always good for one more "pop" so there's money to be made there too but I'll pass.

Caradoc

[Joemoney]

super cheapie QBID (miniscule fraction of a cent) if looking for something quick and >50% probability of decent return within days (TXMC) or weeks (QBID).

I would very careful with QBID - risk is high! They are diluted out and their TV deals are looking questionable. The CEO is lying to many of his promoters.

I would advise caution. But good luck, I could be wrong.

Joemoney

[Joemoney]

Recession Isn't Quite Dead Yet

The official economic caller, the National Bureau of Economic Research, said many key gauges still show recession. It will date the recession's end later, perhaps months after it ends. The group deleted a sentence from an earlier statement that there's no indication of a bottom yet. The NBER may suspect the bottom is near.

Source: IBD's Top 10

[Joemoney]

Regarding NT

I am now taking my recommendation OFF of NT. Because of the recent news and fears dim earnings outlook, I do not believe NT is such a strong buy. It is still tempting to consider buying at this price, but I would be very careful.

Stocks Sag; Nortel Reignites Jitters
http://biz.yahoo.com/rb/020212/business_markets_stocks_dc_12.html

Quote: http://finance.yahoo.com/q?s=nt&d=t

Joemoney

[Caradoc]

Joemoney: Will probably buy ORCH and maybe DNAP if there's an interim low in August or September.

Would play cheapie TXMC (less than 2 cents) and super cheapie QBID (miniscule fraction of a cent) if looking for something quick and >50% probability of decent return within days (TXMC) or weeks (QBID).

You're right about Nortel. Most important for nearterm, it bounced nicely off low caused by unpleasant revelations. Fair probability of taking profit Wednesday at 7.25 or so, but 6-month chart shows double resistance at/near 8.50 bracketing the interim high of 9.

Evenso, a 10 or 12% return doesn't do much for me because I've been spoiled by the volatility of OTC:BB stocks (yes, 99.99% of which are absolute garbage.) I recently missed PWTC's low of .27 by 2 cents, but my .29 shares are looking prett y good. In theory, a penny stock that looks like better than a 10% chance of being a ten bagger is a good bet. For what it's worth, my assessment of PWTC's patents and low overhead business model says lot bigger than 10% probability of being a lot better than a 10 bagger. Or a 20-bagger for that matter.

Good fortune to you!

Caradoc

[Joemoney]

U.S. stocks rally on hopes for economic rebound

By Denise Duclaux

NEW YORK (Reuters) - Stocks rallied for the second straight session on Monday, boosted by companies like chemical maker DuPont Co. (NYSE:DD - news), as expectations for an economic rebound overshadowed fears of shady accounting practices.

``The market has finally begun to look beyond the Enron cloud and respond to what we believe are very positive fundamentals,'' said Milton Ezrati, a senior economic strategist at Lord Abbett & Co., which manages $42 billion in assets.

Cyclical shares like DuPont climbed as investors positioned themselves for an anticipated recovery in the U.S. economy this year. Wireless technology company Qualcomm Inc. (NasdaqNM:QCOM - news) and conglomerate Tyco International Ltd. (NYSE:TYC - news) bounced back after being pounded by accounting concerns.

Stocks gathered momentum throughout the session. The blue-chip Dow Jones industrial average (.DJI) racked up a 140.54-point gain, up 1.44 percent at 9,884.78. The technology-packed Nasdaq Composite Index (.IXIC) climbed 27.78 points, or 1.53 percent, at 1,846.66. The broad Standard & Poor's 500 Index (.SPX) rose 15.72 points, or 1.43 percent, to 1,111.94.

Stocks snapped a five-session losing streak on Friday -- putting an end to the longest string of losses in the market since last September in the wake of the attacks on the United States. Investors are still on edge after the blockbuster bankruptcy of energy trader Enron Corp. , but panic over the prospect of another accounting scandal has subsided.

``A lot of this is a nice bounce back, because we were down for so many days last week and that selling is played out,'' said Edgar Peters, chief investment officer at PanAgora Asset Management Inc., which manages $15 billion. ``This will be a tough year though. We will see a lot of sideways volatility. The real rally won't start until we see real earnings growth.''

Winners trounced losers by a ratio of 2 to 1 on the New York Stock Exchange and 4 to 3 on Nasdaq. More than 1.1 billion shares changed hands on the Big Board and more than 1.5 billion on Nasdaq.

Oil stocks added more fuel to the market after oil prices rocketed to a one-month high. Fears surfaced that a U.S. government decision to buy more than 18 million barrels of crude for its stockpiles would create a supply shortage in March.

Exxon Mobil Corp. (NYSE:XOM - news), the world's largest publicly traded energy company, rose 21 cents to $38.50. Offshore oil and gas driller Noble Drilling Corp. (NYSE:NE - news) tacked on $1.09 gain to $31.78. The Philadelphia Stock Exchange oil service index (.OSX) rallied 3.81 percent.

DuPont climbed $1.84 to $44.56, boosting the blue-chip Dow. The largest U.S. chemical company said it could spin off its $6.5 billion textiles and interiors businesses as part of a broad restructuring.

Forest products company International Paper Co. (NYSE:IP - news) rose $1.82 to $43.81, and aluminum heavyweight Alcoa Inc. (NYSE:AA - news) rose $1.31 to $35.73. Diversified manufacturer Minnesota Mining & Manufacturing Co. (NYSE:MMM - news), up $2.80 at $114.01, and construction equipment maker Caterpillar Inc. (NYSE:CAT - news), up $1.28 at $49.78, also boosted the Dow.

A number of companies battled investors' suspicions about the honesty of Corporate America's accounting practices. Qualcomm rose $3.82 to $41.28 after defending its books on Friday following a research firm's report that raised concerns about the wireless technology firm's accounting.

Tyco rose $1.92 to $31.80 and was the most active share on the New York Stock Exchange. The conglomerate bounced back from a beating taken as investors questioned its accounting.

``People are getting more comfortable with the whole accounting issue ... Companies are coming out pretty quickly when they are attacked,'' said Owen Fitzpatrick, head of the U.S. Equity Group at Deutsche Bank Private Banking.

``It's less of an issue,'' Fitzpatrick said, but he cautioned: ``I wouldn't say it's going to go away any time soon.''

Web gear giant Cisco Systems Inc. (NasdaqNM:CSCO - news) and optical networking company Ciena Corp. (NasdaqNM:CIEN - news) rallied after signing contracts worth millions of dollars to supply equipment for long-distance telephone carrier AT&T Corp.'s (NYSE:T - news) optical network. Ciena rose $1.01 to $10.47. Cisco added 93 cents to $17.69, ranking as the most active on Nasdaq.

Telephone and data services company Qwest Communications International Inc. (NYSE:Q - news) fell 24 cents to $9.36. Qwest said it received a subpoena for documents pertaining to bankrupt telecommunications company Global Crossing Ltd. from the U.S. Securities and Exchange Commission.

WorldCom (NasdaqNM:WCOM - news) fell 38 cents to $7.80. Standard & Poor's cut WorldCom's rating outlook to ``negative'' from ''stable'', saying the No. 2 U.S. long-distance phone company may have difficulty reducing debt as its revenues and earnings fall.

Semiconductor stocks buoyed the Nasdaq. Credit Suisse First Boston raised its rating on Micrel Inc. (NasdaqNM:MCRL - news), which rose $1.95 to $21.74, and National Semiconductor Corp. (NYSE:NSM - news), which gained 87 cents to $27.15, on expectations the sector has reached bottom. The Philadelphia Stock Exchange's semiconductor index (.SOXX) rose 3.80 percent.

Gold-related shares, among the worst performers in the S&P 500, took a hit after Prudential Securities slashed its rating on Newmont Mining Corp. (NYSE:NEM - news) to ``sell'' from ``hold'' and cut its price target on the stock to $10 from $21. Newmont slumped $1.50 to $23.50.

http://biz.yahoo.com/rb/020211/business_markets_stocks_dc_10.html

[Joemoney]

Welcome Caradoc!

Are you using the chairmail function?

We will be in the future. As the club grows, and more interest builds, the Chairmail feature will come in handy.

As self-introduction, I've been saying since March of 2001 not to expect the market to improve until October of 2002

You may be right. Hopefully earnings will improve and the market will return to bullish land sooner than expected. I'm sick of this bearish non sense, lol.

but it's starting to look like my PWTC dreams may come true.

I've heard of PWTC, but had forgotten all about it. Looks like they are really breaking into Asia.

For newbies:
Power Technology Begins Discussions With Major Middle East Gas Producer
http://biz.yahoo.com/iw/020211/037920.html

Power Technology To Establish Pipelink Technology In China
http://biz.yahoo.com/iw/020130/037400.html

Are you following any other stocks? I'm watching closely NPCT and have my eye on a few others. As far as big caps go, NT looks good at this price.

Joemoney

[Caradoc]

Hello! Just found link on Arch's board, skimmed posts here, and added a boardmark. Are you using the chairmail function?

As self-introduction, I've been saying since March of 2001 not to expect the market to improve until October of 2002
http://www.investorshub.com/boards/read_msg.asp?message_id=67086

and that in the meanwhile there may be a few cheapie stocks will be worthwhile. Turns out I was dead wrong about CDDD (ouch!) but it's starting to look like my PWTC dreams may come true.

Regards to all,

Caradoc

[stocko4949]

LOL..went about 10 years,,,making money every year,,,,paid all expenses,,,etc etc,,and stuck a couple grand in my pocket,,,but then,,ha ha,,,then sort of went downhill,,,with lesser quality horses,,,and I really haven't made money the last 4 or 5 years.....but,,,it's really enjoyable. Love the trip.

RE: Handicapping horses,,,well, a few years ago, I almost went into business writing a tout sheet for Oaklawn,,and some other tracks,,,but ahhh decided against it. but would have been fun. I am better at handicapping horses than I am at stocks,,,,but tend to like the challenge,,lol...

If its fun, I'm interested,,,once it becomes a "JOB",,,I'm outta there,,LOL.

[husker]

So do you make money on the ponies? I guess not because you still keep trading stocks! <GRIN>

DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have

[stocko4949]

Thanks Joe- First of all, I would like to say,,,,I know ZIP-NADA-ZILCH about T/A ,LOL

but on CCUR, could you give me the "support line' in a "number"?

to me, On a 1 yr chart is looks like about 12.50, and on a 5 yr chart it looks like about 7.50,,,,am I confusing "price support" with your "upward trending support",..? (don't laugh at me,,I said I knew nothing about TA,,)

CCUR is one I like to buy and hold, but as stated, have been trading, ( to pay for trips to Harrahs, crappie fishing, and upcoming horse racing season in Hot Springs Ark. LOL).

Stocko

[Joemoney]

I got in on NT @ 5.60 and sold mostly around 8. Nice little gain for a 3 month trade. It was my save haven last fall. I'm buying more soon.

Joemoney

[Joemoney]

CCUR is not far away from an upward trending support line.

http://finance.yahoo.com/q?s=CCUR&d=c&t=1y&l=on&z=b&q=l

Joemoney

[stocko4949]

I do own a little NT,,,but please,,,,don't ask what I paid for it,,,,LOL....but if you like that one,,,,

i sold LU at 81,,again,,happy puppy,,,,and just recently bought back some at 6.24,,,,may be risky, but,,,under the right circumstances,,it could move quickly,,,we'll see. Not proud enough of it to say...got get em though. Just decided to take a flyer on some.

[Joemoney]

Don't be victimized by hypers, but OTCBBS can be rewarding.

Joemoney

[stocko4949]

not much on BB's,,,but,,,hmmm..vulnerable !

[stocko4949]

In Fact, i would reccomend trading CCUR, for those so inclined. Look at daily charts on it.

[stocko4949]

OH,,penny stocks,,,? I do own some WWWN and DNAP. (thats all I can say about them LOL) Also wgmgy-but thats not a popular topic, LOL.


Also will mention, several years ago,,,I bought CCUR at 2 1/4,,,sold it at 17, cleared about 15K,,,I was a happy puppy. In the latest crash, it got under 5 but I was afraid to get back in. NOw,....I have been trading it some. example: bgt, 1/29 at 13.17, sold 1/31 at 14.14, last bgt 2/4 at 12.25, it jumped to 13.53, but I missed it,,,but will probably sell tomorrow,,,,anything over 13.25,, (my problem is that I am not around much to watch the puter of late).

It seems to have that 12 to 15 dollar range,....and I can get in and out easily,..and it fluctuates quite well.

Stocko

[Joemoney]

Interesting stat I found.

Overall Number of Securities

Securities Quoted Exclusively on Pink Sheets 3972
Securities Quoted Exclusively on OTC Bulletin Board 1896
Yellow Sheets Bonds 2386
Securities Dually Quoted on Pink Sheets and OTC BB 1892

http://www.pinksheets.com/ bottom of page.

Joemoney

[Joemoney]

NT, one of my previous recommendations is looking like a buy again.

http://finance.yahoo.com/q?s=NT&d=c&k=c4&t=5d

Analysts upgraded it and it was up 9% today. Bottomed out last week.

Joemoney

[Joemoney]

stocko4949

Are you into OTCBBs much? I've been watching NPCT for years and they are now starting to get near signing contracts. They are starting production of their technology and their future is looking bright.

http://ragingbull.lycos.com/mboard/boards.cgi?board=NPCT&read=67529

Are you visited willywizard's club? He speaks of this stock a lot.

Joemoney

[husker]

Well - I suppose I'm supposed to remember who Joe is from some prior life?? LOL - to many migrains has screwed up that part of my brain matter.


DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have

[stocko4949]

WEll,,,,shucks,,,,,Husker,..(as he bats an eye, blushing,...with tilted head),

(Joe-,,he is just trying to butter me up...thinking he might get a valentine from me,,HAH).

Glad to be here!

[stocko4949]

Thanks Joe,,,,

I orginally bought only a 50 shares,,,,at a high price,,LOL...was around 60, but have added 400 under 9...without digging it out,,,a 100 about 8.75 , then 300 at 7.90,,,and there is another 50,,somewhere.,but don't remember,,,,I have 3 accounts,,,and it tends to get to be a mess...LOL.. (this is one of those,,,"averaging" situations,,,LOL). A mention, I did own some GLW, and fortunately, sold it high, so I kindof figure I am about even- steven on JDSU.

All in all, I haven't been trading much of late, as I suspect many others in the same boat. But I have the feeling that will be changing in the near future. I have laid low just holding my stalwarts, such as GE, WMT, PFE, etc,,,,and hanging on with CSCO, QCOM, SUNW, etc. have recently added a little EMC, and I like FNSR, for some reason?? (got a couple 100)

For something solid, I really like NICK, even though it doesn't trade much, (a secondary lending co.), not much float, etc etc, but it makes money,.... consistently, has a very low PE, is a well run company, and sooner or later, as people begin to look for value,...I think it can make a move.
They just attended (feb 3rd i think) a symposium thing-a-ma-jig ,,,LOL,,,in Atlanta,,,,with over 400 investors, and handed out over 200 investor packages,...I will know more about this later,...but things are looking good to me-presently holding 7,000 shares. (confession, I sold quite a bit off around Sept. as it took a good run up on 2 for 1 splite neww, but am trying to buy back,,,under 4).

Now I'm getting carried away,....as I usually do,....If your giving out opinions,,,,,I would be mostly interested in what you think about FNSR and NICK,,

Thanks, Stocko

[Joemoney]

Stock Market Set to Rise; Outlook for the OTCBB
http://www.otcbbnn.com/active/rise0211.htm

[Joemoney]

NanoPierce Technologies Inc. Founds Smart Inlay Production Company ``ExypnoTech GmbH'' in Germany

DENVER--(BUSINESS WIRE)--Feb. 11, 2002--NanoPierce Technologies, Inc. (OTCBB:NPCT - news) today announced the foundation of a new wholly owned subsidiary ``ExypnoTech GmbH'' for smart inlay production.

The ExypnoTech subsidiary will be led by the experienced management team of NanoPierce Card Technologies GmbH (in addition to their current responsibilities). Dr. Michael E. Wernle has been appointed President and Chief Executive Officer; Mr. Bernhard Maier, Chief Operating Officer; Mr. Michael Kober, Chief Technology Officer; and Mr. Richard Lancaster, Chief Financial Officer. Mr. Bernhard Maier will devote full-time executive responsibility to ensuring the timely commissioning of the ExypnoTech production facilities.

ExypnoTech will become the first company in the world using the benefits of the newly developed WaferPierce(TM) flip-chip process developed by another subsidiary of NanoPierce, NanoPierce Connection Systems Inc. (Press Release dated January 15, 2002, ``NanoPierce Technologies To Commence WaferPierce Production''), Colorado Springs, Colorado, for high-volume production of low-cost RFID smart inlays and tags. Following a ramp-up phase for equipment and personnel, high-volume production is expected to start in the second half of this year (Press Release dated January 14, 2002, ``Smart Inlay Production At NanoPierce Card Technologies, GmbH To Be Spearheaded By Bernhard Maier, New Director Of Operations'').

Rudolstadt, in the German region of Thuringia, will be the site of the new production facilities of ExypnoTech, approximately 300 km north of the NanoPierce Card Technologies GmbH offices in Hohenbrunn near Munich in Bavaria, Germany. The impressive location, ``Innovations- und Gruenderzentrum (IGZ) Rudolstadt'' (www.igz-rudolstadt.de), has been carefully selected because of its resources to support the development of young technology companies and because of the abundant availability of skilled technology personnel. The region is well known for high-technology initiatives and production, which, among many others, includes companies such as Fujitsu/Siemens, IBM and Carl Zeiss Jena.

Dr. Michael E. Wernle, President and CEO of NanoPierce Card Technologies, said: ``Everyone at NanoPierce has been working hard to make this big and important step for the Company. I am more than ever convinced that ExypnoTech will very soon become one of the key players in the rapidly growing RFID market because of our highly cost-effective production capabilities with WaferPierce(TM) and by partnering with leading companies in this industry.''

Paul H. Metzinger, President and CEO of NanoPierce Technologies, Inc., commented: ``The NanoPierce Team has achieved a significant goal. Through our ExypnoTech subsidiary we can now offer flexible, cost-effective production and technical capability to serve the explosive market for smart inlays for RFID systems. Effectively, we are 'Open For Business' today. We are on target to begin deliveries in the second half of this calendar year. As I mentioned in our Press Release dated January 14, 2002, 'According to a 1999 Venture Development Corp. Study, 'Global Markets and Applications for Radio Frequency Identification Equipment and Systems,' the market for RFID systems will be about $1.6B in 2002 and its expected to grow 25% annually for the next five years. They predict that end-to-end tracking of materials used in the complete supply chain in all manufacturing industries may be the next killer application for RFID tags.' I see a strong opportunity in a market measured, in the near future, in annual units of billions. This market is characterized, in many applications, by one-time usage, disposable devices. Bottom line, this eventually translates into growing revenues and recurring income.'' Mr. Metzinger further noted, ``Our capital investment is relatively small compared to our projected return on investment.''

About NanoPierce Technologies, Inc.

NanoPierce Technologies, Inc. of Denver, Colorado, USA, is traded on the NASDAQ stock market (OTCBB:NPCT - news) as well as on the Frankfurt and Hamburg (OTC:NPI - news). In addition to the 12 patents it owns, NanoPierce has numerous applications pending, others in preparation, and various other intellectual properties related to NanoPierce's proprietary NCS (NanoPierce Connection System). This advanced system is designed to provide significant improvement over conventional electrical and mechanical interconnection methods for high-density circuit boards, components, sockets, connectors, semiconductor packaging and electronic systems.

About NanoPierce Connection Systems, Inc.

NanoPierce Connection Systems, Inc. is a 100% subsidiary of NanoPierce Technologies, Inc., located in Colorado Springs, Colorado. NanoPierce Connections Systems, Inc. has been chartered to undertake high-volume production WaferPierce(TM), a revolutionary and enabling semiconductor wafer treatment for ultra-low cost flip-chip without the necessity of wire bonding, conductive adhesives, or soldering. Typical end-use applications of WaferPierce(TM) include Smart Labels, Smart Cards, and LED arrays. The new subsidiary has taken over all operations and business activities conducted in the Colorado Springs facility. In addition to WaferPierce(TM) production, NanoPierce Connection Systems will be responsible for licensing and new applications of other NanoPierce technologies to add value to electronic components.

For more information on NanoPierce Technologies, Inc., please visit the web site at http://www.nanopierce.com.

This announcement contains forward-looking statements about NanoPierce Technologies, Inc. and its subsidiaries that may involve risks and uncertainties. Important factors relating to the Company's operations could cause actual results to differ materially from those in forward-looking statements and are further detailed in filings with the Securities and Exchange Commission (SEC) available at the SEC's website (http://www.sec.gov). All forward-looking statements are based on information available to NanoPierce Technologies, Inc., on the date hereof, and NanoPierce Technologies, Inc. assumes no obligation to update such statements.



--------------------------------------------------------------------------------
Contact:

NanoPierce Technologies, Inc.
Paul H. Metzinger, 303/592-1010
303/592-1054 (fax)
[e-mail]
or
NanoPierce Connection Systems, Inc.
Dr. Herbert Neuhaus, 719/638-5930
719/638-5933 (fax)
[e-mail]
or
NanoPierce Card Technologies GmbH
Dr. Michael E. Wernle, + 49-8102-8961-0
+ 49-8102-8961-11 (fax)
[e-mail]
or
ExypnoTech GmbH i.G.
Bernhard Maier, + 49-8102-896140
+ 49-8102-896141 (fax)
or
Investor Relations -- Stock Enterprises
James Stock, 702/614-0003

http://biz.yahoo.com/bw/020211/112100_1.html

[husker]

RB and a starnet site that was on Y

DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have

[Joemoney]

A sense of humor is often needed on iHub, lol.

His alias is familiar. At what site do you know him from?

Joemoney

[husker]

Joe
If you hadn't noticed, I
know Stockoo - he's a top notch guy, can be a real asset, plus he's got a real sense of humor!

DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have

[Joemoney]

Welcome stocko!

I would bookmark iHub in your browser, it is a very good site. A lot of people are coming over here and leaving the Yahoo CLubs/Groups mess, and RBs new crappy design.

(curious if I can post here)

Ofcourse you can post here! You actually allowed to post anywhere unless the thread has certain rules. The only rule here is that everyone is invited.

BTW, at prices did you pick up JDSU at? If you don't mind me asking..

Joemoney

[Joemoney]

I found this on the RB thread:

http://ragingbull.lycos.com/mboard/boards.cgi?board=DIGX&read=1067

I couldn't find much on DIGX, I really haven't been following it.

But who doesn't follow JDSU???

I'm looking at JDSU's chart right now, and it's very hard to say where it's going because the TA charts tell me that it's not a good buy, but looking at the company - how could it not be? Perhaps I'm just caught up in the name, but still think they should be trading at higher prices than this. But seeing Enron failing, I would be careful too.

Joemoney

[husker]

Hey Stockoo
I forgot what you told me in the email, I'll be back in a little bit, gotta run out and grab a burger


DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have

[husker]

Let's see if we can help Joe get this board turned around with the market turn around that's going to be taking place???
Right!
Thanks


DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have

[husker]

ps = glad to see you here, stick around this place - it's a mighty fine - investors hub!!

DISCLAIMER - Nothing in the contents transmitted on this board should be construed as an investment advisory, nor should it be used to make investment decisions. There is no express or implied solicitation to buy or sell securities. The author(s) may have